I think CUR will be a good one; as usual, I'm just looking for a 15-20% gain and then I'm out. I don't try to hit homeruns, singles are fine.
As for AMRN, made a ton in 2011 playing their successful MARINE trial, been in and out small a few times since, but not a fan now. IMHO no way they're ever going to get accelerated approval for Vascepa, and I'd like to know how you've determined that institutions are adding shares. In fact, I believe they've been selling shares.
But since you realize it's a long shot, and sometimes they actually work out, I wish you the best of luck.
All that is needed to make a happy life is within yourself, in your way of thinking. -Marcus Aurelius